Orion Corp - Company Profile
Powered by 
All the data and insights you need on Orion Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Orion Corp Strategy Report
- Understand Orion Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Orion Corp (Orion) is a pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). It offers these products to healthcare service providers and professionals, such as doctors, pharmacies, hospitals, healthcare centers, clinics and laboratories. Orion’s drugs span the core areas of central nervous system (CNS), oncology and respiratory. The company operates through a single segment: Pharmaceuticals. The segment develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Orion's research and development efforts in the pharmaceutical industry are centered on pain management and oncology. Additionally, Orion is involved in the development of veterinary medicines as well as generic drugs. In FY2023, the company spent EUR126.9 million towards its R&D activities, representing a 0.004% of total revenue. The company’s major pipeline products include Aranote, Arastep, OMAHA 1, OMAHA2a, Cypides, ODM-105, ODM-111, ODM-212 in Phase III for the treatment of prostate cancer and solid tumours and pain respectively. Orion's primary focus areas for pharmaceutical research are oncology and pain management, alongside the development of veterinary drugs and selected generics. The company's key clinical development initiatives are detailed in the following table. In early-stage research, Orion is exploring various projects related to cancer and pain. Furthermore, ongoing projects aim to introduce new veterinary drugs and selected generic medications. In collaboration with Propeller Health, Orion is actively engaged in a development project that involves equipping the Easyhaler device with a sensor to monitor its usage. Additionally, Orion is pursuing two clinical projects in digital therapies. One project, ODD-402, conducted in partnership with Healthware Group, seeks to enhance the care of Parkinson's patients through a digital tool that collects patient data to personalize and improve treatment. Orion has also licensed ODD-403, a digital therapeutic (DTx) designed for patients with chronic pain and a fear of movement and re-injury, to Newel Health. Under the agreement, Newel holds the global exclusive rights for the development, manufacturing, and commercialization of ODD-403. Orion stands to receive royalties from product sales, as well as sales milestone payments.
Product Categories
- Animal Health
- Branded Products
- Fermion and Contract Manufacturing
- Generics and Consumer Health
- Innovative Medicines
- Translation Differences and Other Operations
Overview
Offers animal sedatives in the Nordic region and in Eastern Europe. Manufactures and promotes both proprietary and generic drugs for livestock, domestic animals and pets. Offers a wide range of drugs for animal health which comprises Dexdomitor (dexmedetomidine), Domitor (medetomidine), Domosedan (detomidine) and Antisedan (atipamezole). Provides parasite drugs for cats and dogs, Ketoprofene painkillers and the Aptus products for animal well-being. Also markets and sells veterinary drugs of various international companies in the Nordic countries.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Fermion: Manufactures Orion’s proprietary drugs and markets active ingredients. It provides contract manufacturing services to develop and manufacture new active pharmaceutical ingredients. Contract Manufacturing: Manufactures and sells pharmaceutical drugs to other companies. Develops painkillers, drugs for brain cancer, prostate cancer and testosterone replacement.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
It includes generic (off-patent) prescription drugs (including biosimilars) and self-care products. It has a presence in four geographic regions includes Eastern Europe, Finland and Baltics, Scandinavia, and Rest of the World
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
It includes medicines with patent or other product protection. Its treatment is available in 80 countries globally.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer